glp-1 and gip receptor agonist Dual GIP/GLP-1 agonists: New advances for treating type-2 diabetes GIP Receptor Agonism Attenuates GLP-1

Naturally occurring mutations in G protein-coupled receptors associated with obesity and type 2 diabetes mellitus

There is no penalty for going slower

Glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes: past, present, and future

This enhancement is demonstrable through an increase in mitochondrial DNA content, the upregulation of genes integral to mitochondrial biogenesis, and the increased expression of proteins pivotal in oxidative phosphorylation

The body will continue to send the cues and signals it wants to send, in whatever form it needs to send them until it communicates what it wants you to know

PubMed Central, Perry, TracyAnn, et al